Cornelia M. Weyand, MD, PhD; Kevin C. Hicok, MS; Gene G. Hunder, MD; Jorg J. Goronzy, MD, PhD
Weyand CM, Hicok KC, Hunder GG, Goronzy JJ. Tissue Cytokine Patterns in Patients with Polymyalgia Rheumatica and Giant Cell Arteritis. Ann Intern Med. 1994;121:484-491. doi: 10.7326/0003-4819-121-7-199410010-00003
Download citation file:
Published: Ann Intern Med. 1994;121(7):484-491.
To analyze temporal artery specimens from patients with giant cell arteritis and polymyalgia rheumatica for the presence of inflammatory cytokines and to ascertain whether a specific cytokine pattern exists for the two conditions.
Case series of patients having temporal artery biopsy procedures.
The outpatient clinic and the research laboratories of the Division of Rheumatology, Mayo Clinic.
34 patients having temporal artery biopsy procedures: 15 patients had giant cell arteritis, 9 had polymyalgia rheumatica without evidence of vasculitis, and 10 had neither polymyalgia rheumatica nor vasculitis.
Temporal artery specimens were analyzed for in vivo presence of cytokine messenger RNA (mRNA) by polymerase chain reaction with cytokine-specific primer sets.
Vasculitic lesions in giant cell arteritis samples were characterized by in situ production of interleukin-1 β, interleukin-6, and transforming growth factor-β 1 mRNA (indicative of macrophage activation) and by interferon-γ and interleukin-2 mRNA (indicative of selective T-cell activation). However, macrophage- and T-cell-derived cytokines were also detected in temporal artery biopsy specimens from patients with polymyalgia rheumatica. Tissue-infiltrating T cells in giant cell arteritis and polymyalgia rheumatica samples each had distinctive lymphokine profiles. Although interferon-γ was found in 67% of giant cell arteritis samples, polymyalgia rheumatica samples had only interleukin-2.
Patients with polymyalgia rheumatica have vascular involvement. Patients with polymyalgia rheumatica and giant cell arteritis share in situ production of mRNA specific for macrophage-derived cytokines. T cells recruited to vasculitic lesions in patients with giant cell arteritis predominantly produce interleukin-2 and interferon-γ. Patients with polymyalgia rheumatica do not have interferon-γ production, suggesting that interferon-γ may be involved in the progression to overt arteritis.
Learn more about subscription options.
Register Now for a free account.
Neurology, Rheumatology, Vasculitides, Giant Cell Arteritis/Polymyalgia Rheumatica.
Results provided by:
Copyright © 2016 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use
This PDF is available to Subscribers Only